Complete Blood Count, Complete Metabolic Panel (Chemistries) and Lipids - NBI
Complete Blood Count, Complete Metabolic Panel (Chemistries) and Lipids - NBI

Complete Blood Count, Complete Metabolic Panel (Chemistries) and Lipids

Regular price $56.00

This panel includes the three most common routine blood tests: complete blood count with differential and platelets, a complete metabolic panel (chemistries) and a lipid profile.

What’s Reported

Red Blood Cells and Indices

  • Red Blood Cells (RBC)
  • Hemoglobin
  • Hematocrit
  • Mean Corpuscular Volume (MCV)
  • Mean Corpuscular Hemoglobin
  • Mean Corpuscular Hemoglobin Concentration
  • Red-cell Distribution Width

White Blood Cells

  • White blood cells (WBC)
  • Absolute and Percent Neutrophils
  • Absolute and Percent Lymphocytes
  • Absolute and Percent Monocytes
  • Absolute and Percent Eosinophils
  • Absolute and Percent Basophils


  • Platelet Count
  • Mean Platelet Volume

Manual Differential

  • If abnormal cells are noted on a manual review of the peripheral blood smear or if the automated differential information meets specific criteria, a full manual differential will be performed.

Blood Sugar

  • Glucose

Electrolytes, Acid-Base (pH) Balance  and Minerals

  • Carbon Dioxide
  • Calcium
  • Chloride
  • Potassium
  • Sodium

Kidney Function

  • Blood urea nitrogen (BUN)
  • BUN/Creatinine Ratio (calculated)
  • Creatine
  • Estimated glomerular filtration rate (eGFR)

Liver Function

  • Albumin
  • Albumin/Globulin Ratio (calculated)
  • Alkaline Phosphatase (ALP)
  • Alanine Aminotransferase (ALT)
  • Aspartate Aminotransferase (AST)
  • Bilirubin (total)
  • Calcium
  • Globulin (calculated)
  • Protein (total)


  • Total Cholesterol
  • HDL Cholesterol
  • Triglycerides
  • LDL-Cholesterol (calculated)
  • Cholesterol/HDL Ratio (calculated)
  • LDL/HDL Ratio (calculated)
  • Non-HDL Cholesterol (calculated)
How to prepare

Fasting: Yes. Fast for 10-12 hours before taking this test.

Water: Drink plenty of water to stay hydrated.

Medications: Take all medications as prescribed.

How long until you get the results

1-2 Business days
Result turnaround times are estimates and not guaranteed. Due to factors outside of our control, such as weather, holidays, confirmation/repeat testing or equipment maintenance, our lab may require additional time to complete tests.

More about this test

White Blood Cells

White Blood Cells (WBCs). There are five types of WBCs. All are important for fighting infections. High WBCs, or elevated amounts of specific WBCs, may indicate you’re fighting an infection or have inflammation somewhere in your body. Low numbers of WBCs may increase your risk for infections.

Differential. The differential measures the percentages of the different types of WBCs. It also shows if there are any abnormal or immature cells.

Red Blood Cells and Indices

Hematocrit (Hct). This results shows how much of your whole blood is made up of red blood cells. A low Hct may indicate blood loss (eg, from bleeding). Or it could point to possible iron deficiency anemia or other disorders. Dehydration or other disorders can cause an elevated Hct.

Hemoglobin (Hgb) is the protein in red blood cells that carries oxygen from your lungs to the rest of your body. Among other possible reasons for this, low Hbg can be caused anemia, lead poisoning and blood loss.

Mean corpuscular hemoglobin (MCH) measures how much hemoglobin your red blood cells have. Low MCV can occur with anemia, lead poisoning and rheumatoid arthritis. A high MCV implies your red blood cells are larger than normal and can point to possible deficiencies in vitamin B12 and folic acid, liver disease or other potential underlying causes.

Mean corpuscular hemoglobin concentration (MCHC) is a calculation of the average concentration of hemoglobin inside a single red blood cell.

Mean corpuscular volume (MCV) is the average size of your red blood cells. MCV increases RBCs get bigger. This can occur when you have low vitamin B12 or folic acid. A low MCV can indicate other types of anemia, such as iron deficiency anemia.

Red blood cells (RBCs). RBCs play the vital role of delivering oxygen to tissues throughout your body and removing carbon dioxide from cells. Once the carbon dioxide is picked up the RBCs, they carry this toxin your lungs where the carbon dioxide is breathed out, thus removing it from your body. Too few RBCs can indicate you have anemia or other diseases and cause fatigue, depression and shortness of breath. Elevated RBCs can cause problems with blood flow and increase your risk for blood clots, heart attack, stroke, enlarged liver and spleen.

Red cell distribution width (RDW) indicates how much the size of your red blood cells vary. Red blood cells last for about 90 days. Young RBCs that have just been produced by your bone marrow are small and they get larger as they mature. An elevated RDW is one result doctors look at in determining if you have anemia and what type of anemia it might be.

Platelets are cell fragments that play a role in blood clotting. Too few platelets may mean you have a higher risk of bleeding. Too many platelets mean you have an increased risk for blood clots, heart attack and stroke.


Elevated LDL cholesterol and triglycerides are associated with increased heart disease risk. When too much low-density lipoprotein (LDL) circulates in the blood, it can slowly build up in the walls of the arteries that feed the heart and brain.

Together with other substances it can form plaque, a thick, hard deposit that can clog arteries. This condition is known as atherosclerosis. If a clot forms and blocks a narrowed artery, it can cause a heart attack or stroke.

In contrast, higher HDL cholesterol is associated with decreased heart disease risk. HDL cholesterol helps to transport cholesterol away from the arteries and back to the liver, where it is metabolized and removed from the body.

Low levels of high density lipoprotein (HDL) cholesterol are as much a risk factor for CAD as high LDL cholesterol. For these reasons, LDL cholesterol is sometimes referred to as “bad cholesterol” and HDL “good cholesterol.”

If your LDL cholesterol is high, bringing it down may decrease heart disease risk. Based on epidemiological data from the Framingham Offspring Study and the Munster Heart Study, it has been estimated that each one percent decrease in LDL cholesterol decreases the risk of major cardiovascular events by 1.0 to 1.5%. 

Since HDL cholesterol is associated with decreased cardiovascular disease risk, it’s not surprising that increasing HDL cholesterol is protective. Each 1 mg/dL increase in HDL cholesterol is associated with a 2%-3% decrease in CHD risk, even after adjustment for other risk factors, and predicts heart disease risk regardless of LDL levels.

Despite efforts by the medical and public health communities to increase awareness of the risks of poor lipid control and encourage lipid screening, patients often are inadequately treated, and less than 40% reach National Cholesterol Education Program (NCEP) low-density lipoprotein (LDL) cholesterol targets with monotherapy.

Testing your lipids and knowing your numbers is important for taking charge of your health and reducing your heart disease risk.

Blood Glucose

Glucose. The kidneys filter glucose out of the blood. Elevations in glucose can indicate pre-diabetes or diabetes and place a significant strain on the kidneys.

Electrolytes, Acid-Base (pH) Balance  and Minerals

Calcium. Low calcium is common in people with kidney failure. Other diseases that have been associated with abnormal blood calcium such as thyroid disease, parathyroid disorder, malabsorption, cancer, or malnutrition.

Carbon dioxide. Carbon Dioxide (CO2) is a waste product eliminated by the body through breathing and by the kidneys. Carbon dioxide is a measure of the amount of carbon dioxide gas in your blood and assists in evaluating how acidic your blood is and your electrolytes. Electrolytes help balance the levels of acids and bases in your body. Most carbon dioxide in your body is in the form of bicarbonate, which is a type of electrolyte. Electrolyte imbalances can occur in kidney diseases, lung diseases, and high blood pressure.

Chloride. Chloride is an electrolyte that can give an indication of acid-base balance and hydration status.  It works with other electrolytes such as CO2, potassium and sodium.

Potassium (K+). Potassium (K+) is a major mineral inside cells. Potassium is excreted by the kidneys and its concentrations depend on many factors, including aldosterone, sodium resorption, and acid-base balance. 

Sodium (Na+). Sodium (Na+) is the major mineral in the spaces surrounding cells, called the extracellular space.  Sodium plays a major role in how much water flows into and out of cells. Serum sodium levels are the result of a balance between the dietary intake of sodium and its elimination by the kidneys. 

Kidney Function

Blood urea nitrogen (BUN). The BUN test is an indicator of kidney health, is primarily used with creatinine to help diagnose kidney disease, and to monitor people with acute or chronic kidney disease. Urea is a breakdown product of protein, and the BUN level can be an indicator of how well the kidneys are filtering the blood.

BUN/Creatinine Ratio. The BUN/Creatinine Ratio is used to diagnose acute or chronic kidney disease. Since BUN and creatinine are both filtered in the kidneys, the two together provide an overall kidney function. 

Creatinine. Creatinine is found in high concentrations in muscle. When muscle breaks down it releases creatinine, which is filtered from the blood by the kidneys. Creatinine is one indicator of kidney health.

Estimated glomerular filtration rate (eGFR). Estimated GFR is a measure of kidney function and is calculated based on the level of creatinine in the blood.

Liver Function

Albumin. Albumin is a protein made by the liver. It keeps fluid from leaking out of blood vessels and transports hormones, nutrients and drugs. Albumin is measured to help diagnose liver or kidney disease and to assess nutritional status.  

Globulin (calculated). Globulin is one of the major proteins in the body. It transports proteins, carries minerals and acts as immunoglobulins as part of the immune system.   

Albumin/Globulin Ratio (calculated). The albumin globulin ratio (calculated) can be used to gauge the production of immunoglobulins. A low ratio may reflect the overproduction of globulins, whereas a high ratio suggests under production. 

Alkaline Phosphatase (ALP). ALP can be found in many tissues, but it is mostly found in the liver, biliary tract, and bone.  Measuring this enzyme is important for determining liver and bone disorders.  

Alanine Aminotransferase (ALT). ALT is an enzyme found predominantly in the liver. ALT is measured to screen for liver damage and to diagnose liver disease. 

Aspartate Aminotransferase (AST). AST is an enzyme that’s found in the liver as well as other organs throughout the body, including the heart, kidneys and muscles. AST is measured to screen for liver damage and to diagnose liver disease. 

Bilirubin (total). Bilirubin is the breakdown product of red blood cells in the body. Total bilirubin is measured to screen for or monitor liver disorders or hemolytic anemia. 

Protein (total). Albumin and globulin make up most of the protein found in the body and are involved in a variety of biological processes, including the regulation of osmotic pressure, transport of drugs, hormones and enzymes.


Assmann, G., P. Cullen, and H. Schulte, The Munster Heart Study (PROCAM): results of follow-up at 8 years.Eur Heart J, 1998. 19(Suppl A): p. A2-A11.

Castelli, W.P., Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study. Can J Cardiol, 1988. 4 Suppl A: p. 5A-10A.

Miller, M., Niacin as a component of combination therapy for dyslipidemia. Mayo Clin Proc, 2003. 78(6): p. 735-42.

Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 2000;160(4):459-467.

Wilson, P.W., K.M. Anderson, and W.P. Castelli, Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham Offspring Study. Am J Med, 1991. 90: p. 11-16.